MasterControl Appoints Kelly Starman as Chief Marketing Officer to Drive Global Growth

MasterControl, a leading provider of quality management and manufacturing software solutions, today announced the appointment of Kelly Starman as Chief M...

August 15, 2024 | Thursday | News
Thermo Fisher’s PPD Clinical Research Business Recognized as Industry Leader in Digital Services by ISG

The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been honored for industry leadership in digital ...

August 15, 2024 | Thursday | News
Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News
Renexxion and Dr. Falk Pharma Begin U.S. Patient Dosing in Global Phase 2b Study for Promising Gastroparesis Treatment

Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high u...

August 14, 2024 | Wednesday | News
Parexel’s Greenhouse Gas Reduction Targets Earn SBTi Validation, Marking Key Milestone in Net-Zero Commitment

Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...

August 13, 2024 | Tuesday | News
Persist AI and Nivagen Announce Strategic Collaboration to Transform Long-Acting Injectable Drug Manufacturing

Persist AI and Nivagen have announced a collaboration to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, ...

August 13, 2024 | Tuesday | News
Merck to Acquire Curon Biopharmaceutical’s CN201, Expanding Pipeline in B-Cell Associated Diseases

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Curon Biopharmaceutical (Curon), a privately held biotechnology company, &nb...

August 12, 2024 | Monday | News
Ascendis Pharma’s YORVIPATH® Offers Continuous PTH Therapy, Meeting Critical Needs of Over 70,000 U.S. Hypoparathyroidism Patients

Hypoparathyroidism is a rare endocrine disease with multi-organ impacts affecting an estimated 70,000 to 90,000 people in the United States Ascendi...

August 12, 2024 | Monday | News
MSD Discontinues Phase 3 KeyVibe-008 Trial for Extensive-Stage Small Cell Lung Cancer

Merck (NYSE: MRK), known as MSD outside of the United States and Canada,  announced the discontinuation of the Phase 3 KeyVibe-008 trial based on th...

August 09, 2024 | Friday | News
Integrated DNA Technologies Launches Rapid Genes for Expedited Drug Discovery

To enable pharmaceutical researchers to move quickly into their high‑throughput screening experiments, global genomics solutions provider Integrated DNA ...

August 08, 2024 | Thursday | News
Calibre Scientific Acquires Acefesa, a Provider of Laboratory Consumables and Equipment in Spain

Calibre Scientific is pleased to announce the acquisition of ACEFE, S.A.U. (“ACEFESA” or the “Company”), a Barcelona-ba...

August 07, 2024 | Wednesday | News
Kyowa Kirin International Partners with NewBridge Pharmaceuticals to Distribute Rare Disease Treatments in Middle East and North Africa

Agreement will see NewBridge Pharmaceuticals act as a multi-country distributor in four countries across the Middle East and North Africa (MENA) ...

August 07, 2024 | Wednesday | News
Thermo Fisher Scientific's SeCore™ CDx HLA A Sequencing System Receives FDA Clearance as Companion Diagnostic for Adaptimmune’s TECELRA® TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science,  announced that its SeCore™ CDx HLA A Sequencing System has been granted 5...

August 07, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close